Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C

Raquel Silva Neres-Santos1, Carolina Victoria Cruz Junho1, Karine Panico1

  • 1Laboratory of Cardiovascular Immunology, Center of Natural and Human Sciences (CCNH), Federal University of ABC, Santo André 09210-580, Brazil.

Cells
|November 27, 2021
PubMed

Insights

Vitamin C protects kidneys and offers benefits to the heart in a cardiorenal syndrome model. This antioxidant may prevent damage caused by kidney or heart insults.

Area of Science:

  • Cardiorenal medicine
  • Mitochondrial pathophysiology
  • Antioxidant research

Background:

  • Cardiorenal syndrome (CRS) involves kidney-heart interactions, with Type 3 CRS (CRS3) featuring acute kidney injury preceding cardiac issues.
  • Mitochondrial dysfunction and oxidative stress are key in CRS3.
  • Vitamin C, a known antioxidant, shows protective effects on cardiac, renal, and vascular tissues.

Purpose of the Study:

  • To investigate vitamin C's protective effects on kidneys and heart in an in vivo CRS3 model.
  • To evaluate vitamin C's impact on renal function, mitochondrial activity, and oxidative stress markers post-ischemia-reperfusion (IR).

Main Methods:

  • Unilateral renal ischemia and reperfusion (IR) in mice, with and without vitamin C treatment.
  • Assessment of kidney and heart tissues, including morphometry, serum markers (urea, creatinine), respirometry, NO levels, and gene expression (mitochondrial dynamics, NOS).

Main Results:

  • IR led to reduced kidney weight, impaired renal function, decreased mitochondrial oxygen consumption, elevated NO, and altered Mfn2 expression.
  • Cardiac function showed reduced oxygen consumption and NO levels post-IR.
  • Vitamin C treatment preserved kidney function, reduced NO, modulated NOS expression, and improved oxygen consumption in both organs.

Conclusions:

  • Vitamin C demonstrates protective effects on kidneys and beneficial impacts on the heart following IR injury.
  • Vitamin C may serve as a preventive strategy against cardiorenal insults in CRS3.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
561
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
98
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
188
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
61